Evidence map›Paper›PMID 34267223›Full record

ReviewNature reviews. Disease primers2021

Acute kidney injury.

John A Kellum, Paola Romagnani, Gloria Ashuntantang, Claudio Ronco, Alexander Zarbock, Hans-Joachim Anders

6 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 1,004 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,004citing papers in PubMed, 5 pooled it
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05796661 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluation of Filters Useful Life, Metabolic Control, Electrolyte Profile and Acid-base Balance During Regional Anticoagulation With 4% Trisodium Citrate in Patients Undergoing CVVHDF: Effects of Increased Blood Flow

TypeinterventionalSponsorHospital Israelita Albert EinsteinRan2023 to 2024Enrolled27ConditionsAcute Kidney InjuryArmsEffects of increased blood flow during regional anticoagulation with 4% trisodium citrate in patients undergoing continuous venovenous hemodiafiltration
NCT06328478 unknown statusnot on this mapstarted 2024, after this paper: background citation

Predictors of Acute Kidney Injury in Critically Ill Children Admitted to Pediatrics Intensive Care Unit At Assiut University Children Hospital.

TypeobservationalSponsorAssiut UniversityRan2024 to 2025Enrolled100ConditionsAcute Kidney InjuryArmsObservational prospective study.
NCT06612073 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation Of The Degree Of Kidney Injury in Children With Hypovolemic Shock

TypeobservationalSponsorAssiut UniversityRan2024 to 2025Enrolled85ConditionsEvaluation of Acuty Kidney Injury in Children With Hypovolemic Shock
NCT06717516 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Renal Involvement in Adult Patients With Inflammatory Bowel Disease and Its Relation to Duration and Disease Activity .

TypeobservationalSponsorAssiut UniversityRan2024 to 2026Enrolled100ConditionsIBD and Renal Involement, IBD Activity and Kidney Affection
NCT07286526 phase4completednot on this mapstarted 2024, after this paper: background citation

Comparison of Bolus and Continuous Hydration Regimens for the Prevention of Contrast-Associated Acute Kidney Injury in the Emergency Department: A Randomized Controlled Non-Inferiority Trial

TypeinterventionalSponsorYunus Emre GemiciRan2024 to 2025Enrolled285ConditionsAcute Kidney Injury Following Administration of Contrast MediaArmsBolus hydration therapy, Continuous hydration therapy
NCT07617675 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Perioperative Recombinant Human Brain Natriuretic Peptide for Renal Protection in Cardiac Surgery: the PROTECT-CS Randomized Clinical Trial

TypeinterventionalSponsorChina National Center for Cardiovascular DiseasesRan2026 to 2029Enrolled694ConditionsAKI - Acute Kidney Injury, Cardiac Surgical Procedures, Cardiopulmonary BypassArmsRecombinant Human Brain Natriuretic Peptide (rhBNP), Normal Saline (Placebo)
3 · Its place in the literature

Who cites it

1,004 citing papers in PubMed, 5 syntheses or guidelines pooled it, 534 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

944 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

John A KellumCenter for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-1995-2653
Paola RomagnaniNephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, Italy.
Gloria AshuntantangFaculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde, Yaounde, Cameroon.
Claudio RoncoDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0002-6697-4065
Alexander ZarbockDepartment of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Hans-Joachim AndersDivision of Nephrology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany. hjanders@med.uni-muenchen.de.ORCID http://orcid.org/0000-0003-2434-2956
Austin Hospital · AU

Funding

Phenotyping REnal Cases In Sepsis and surgery for Early Acute Kidney Injury (PReCISE AKI)UH3DK114861 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLUM, JOHN A, PALEVSKY, PAUL M · 2019 to 2021
$900k
NIDDK NIH HHS UH3 DK114861
6 · The paper itself

Abstract

Acute kidney injury (AKI) is defined by a sudden loss of excretory kidney function. AKI is part of a range of conditions summarized as acute kidney diseases and disorders (AKD), in which slow deterioration of kidney function or persistent kidney dysfunction is associated with an irreversible loss of kidney cells and nephrons, which can lead to chronic kidney disease (CKD). New biomarkers to identify injury before function loss await clinical implementation. AKI and AKD are a global concern. In low-income and middle-income countries, infections and hypovolaemic shock are the predominant causes of AKI. In high-income countries, AKI mostly occurs in elderly patients who are in hospital, and is related to sepsis, drugs or invasive procedures. Infection and trauma-related AKI and AKD are frequent in all regions. The large spectrum of AKI implies diverse pathophysiological mechanisms. AKI management in critical care settings is challenging, including appropriate volume control, nephrotoxic drug management, and the timing and type of kidney support. Fluid and electrolyte management are essential. As AKI can be lethal, kidney replacement therapy is frequently required. AKI has a poor prognosis in critically ill patients. Long-term consequences of AKI and AKD include CKD and cardiovascular morbidity. Thus, prevention and early detection of AKI are essential.

Indexed as

Acute Kidney InjuryRenal Insufficiency, ChronicAgedCritical IllnessDisease ProgressionHumansKidney

Identifiers

PMID34267223
OpenAlexW3182617436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.